[Molecular pathology analysis of the KRAS mutation status in patients with metastasized colorectal carcinoma: an initial approach using predictive pathology].

Tannapfel, A

[Molecular pathology analysis of the KRAS mutation status in patients with metastasized colorectal carcinoma: an initial approach using predictive pathology]. [electronic resource] - Der Pathologe Feb 2008 - 93-6 p. digital

Publication Type: Journal Article

1432-1963

10.1007/s00292-007-0966-y doi


Angiogenesis Inhibitors--therapeutic use
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Antineoplastic Agents--therapeutic use
Bevacizumab
Cetuximab
Colorectal Neoplasms--drug therapy
DNA Mutational Analysis
ErbB Receptors--antagonists & inhibitors
Genes, ras
Humans
Mutation
Neovascularization, Pathologic--drug therapy
Prognosis
Proto-Oncogene Proteins--genetics
Proto-Oncogene Proteins p21(ras)
ras Proteins--genetics